Novel Pyrazole Compounds for Inflammatory Disease Treatment

The European Patent Office published patent application EP3759103A1 for novel chemical compounds developed by Inflazome Limited. The compounds are pyrazole derivatives classified under multiple IPC codes including C07D 405/14, C07D 231/18, and C07D 401/12, with therapeutic applications in A61P 29/00 for treating inflammatory conditions.

For pharmaceutical companies and researchers, this patent establishes intellectual property protection for novel anti-inflammatory compounds across 27 designated European member states. The granted patent provides Inflazome Limited with exclusive rights to these compound structures and their therapeutic uses, which may affect freedom-to-operate considerations for other entities developing similar anti-inflammatory therapeutics.